PER
Click for more information
1.25% 8.1¢ percheron therapeutics limited

should buy now, page-11

  1. wormy
    2,405 Posts.
    clock Created with Sketch.
    22/08/11
    06:54
    Post #: 8852245




    ANP have previously reported that ATL1103 injection suppressed circulating levels of IGF-I in primates and that toxicology studies have been completed supporting the Company?s plans to move ATL1103 into clinical development




    (.>_<) !!!! Background Information

    ANP Price at posting: 7.0¢ Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AWJ Jeffrey's Find delivered $6.3M in gold sales for August, says Auric
right-arrow Created with Sketch.
MOV MOVE Logistics picks new interim CEO to take over operations from early September
right-arrow Created with Sketch.
G88 Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results
right-arrow Created with Sketch.
NEWS Appliances and furnishings impress - will Harvey Norman be next?
right-arrow Created with Sketch.
WNX Wellnex sees first special access scheme prescriptions for new Wellness Life brand
right-arrow Created with Sketch.
IMD IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
0.001(1.25%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.3¢ 8.4¢ 8.1¢ $20.51K 249.8K

Buyers (Bids)

No. Vol. Price($)
2 127624 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 28715 1
View Market Depth
Last trade - 13.55pm 19/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.